Trial intelligence / Profile preview

Parenteral Medivitan vs oral vitamin B12 in cobalamin deficiency

2018-003619-23Phase 4Terminated

Sponsor
Medice
Start
Oct 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of Medivitan in vitamin B12 deficiency (2 arms), sponsored by Medice. Primary endpoint: Serum vitamin B12 concentration. Started Oct 2019; status: terminated.

02

Drugs

Medivitan
03

Conditions

vitamin B12 deficiency

Beyond the preview

Go deeper on 2018-003619-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-003619-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call